Published in Scand J Infect Dis on January 01, 2000
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology (2009) 1.58
Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki, Finland. J Virol (2010) 1.08
Origin and dynamics of HIV-1 subtype C infection in India. PLoS One (2011) 0.92
Multiple HIV-1 introductions into the Swedish intravenous drug user population. Infect Genet Evol (2008) 0.89
Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001. J Virol (2004) 0.89
HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries. Virus Evol (2016) 0.80
Acquisition of HIV by African-born residents of Victoria, Australia: insights from molecular epidemiology. PLoS One (2013) 0.79
Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol (1996) 2.83
Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology (1998) 2.76
Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: a new surveillance tool for molecular epidemiology. AIDS Res Hum Retroviruses (1996) 2.75
A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes (1995) 2.08
Solid phase antibody assay by means of enzyme conjugated to anti-immunoglobulin. J Clin Pathol (1976) 2.03
Antibody response in patients with acute pancreatitis to mycoplasma pneumoniae. Scand J Gastroenterol (1973) 2.03
No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet (1998) 2.01
Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res Hum Retroviruses (1996) 1.92
Measles history and atopic diseases: a population-based cross-sectional study. JAMA (2000) 1.81
Serological diagnosis of Mycoplasma pneumoniae infection by enzyme immunoassay. J Clin Pathol (1980) 1.80
HIV-1 genetic diversity. AIDS (1996) 1.69
HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS (1998) 1.50
Enrichment of HFE mutations in Swedish patients with familial and sporadic form of porphyria cutanea tarda. J Intern Med (2004) 1.39
Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol (1993) 1.32
Mumps and rubella eliminated from Finland. JAMA (2000) 1.32
Characterization of subtype A HIV-1 from Africa by full genome sequencing. AIDS (1999) 1.31
Immunoblotting and enzyme-linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2. Intervirology (1985) 1.29
An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I). J Virol (1998) 1.26
Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis (1998) 1.20
Perinatal cytomegalovirus infection in man. Arch Dis Child (1977) 1.19
Seasonal increase in human IgE and IgG4 antisaliva antibodies to Aedes mosquito bites. Int Arch Allergy Immunol (1997) 1.14
Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa. J Virol (1996) 1.14
Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol (2000) 1.11
Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect (2000) 1.10
Letter: Negative complement-fixation tests as an immunopathological finding. Lancet (1974) 1.10
Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective study. Cancer Causes Control (1993) 1.07
Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group. J Infect Dis (1997) 1.07
Frequent occurrence of IgE and IgG4 antibodies against saliva of Aedes communis and Aedes aegypti mosquitoes in children. Int Arch Allergy Immunol (1994) 1.05
Swimming-associated outbreak of Escherichia coli O157:H7. Epidemiol Infect (1999) 1.04
Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine (2000) 1.03
Clinical and virological findings in patients with cytologically diagnosed gynecologic herpes simplex infections. Acta Cytol (1977) 1.03
Herpes simplex virus infection in the newborn. Arch Dis Child (1972) 1.02
A study on HIV and hepatitis C virus among commercial sex workers in Tallinn. Sex Transm Infect (2008) 1.02
Molecular epidemiology of HIV-1 based on phylogenetic analysis of in vivo gag p7/p9 direct sequences. Virology (1993) 1.01
Cytopathogenicity of cytomegalovirus to human ecto- and endocervical epithelial cells in vitro. Acta Cytol (1975) 1.00
Serological characterisation of Ureaplasma urealyticum strains by enzyme-linked immunosorbent assay (ELISA). J Clin Pathol (1982) 0.99
Virtually full-length sequences of HIV type 1 subtype J reference strains. AIDS Res Hum Retroviruses (1999) 0.98
Epidemiology of Sindbis virus infections in Finland 1981-96: possible factors explaining a peculiar disease pattern. Epidemiol Infect (2002) 0.98
No measles in Finland. Lancet (1997) 0.97
Screening for HIV in medicolegal necropsies in Helsinki. BMJ (1989) 0.96
An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network. AIDS Res Hum Retroviruses (2000) 0.96
Antibody response to rubella virion (V) and soluble (S) antigens in rubella infection and following vaccination with live attenuated rubella virus. Arch Gesamte Virusforsch (1971) 0.95
Epidemiology of rubella in Finland. Euro Surveill (2004) 0.95
Cutaneous reactivity to mosquito bites: effect of cetirizine and development of anti-mosquito antibodies. Clin Exp Allergy (1991) 0.94
Endoproteolytic cleavage of HIV-1 gp160 envelope precursor occurs after exit from the trans-Golgi network (TGN). Arch Virol (1995) 0.94
Fatal cytomegalovirus infection in a previously healthy boy with myocarditis and consumption coagulopathy as presenting signs. Scand J Infect Dis (1972) 0.92
Incidence of cytomegalovirus infections in early childhood. Scand J Infect Dis (1972) 0.92
An international outbreak of Vero cytotoxin-producing Escherichia coli O157 infection amongst tourists; a challenge for the European infectious disease surveillance network. Epidemiol Infect (1999) 0.92
Detection of mosquito saliva-specific IgE antibodies by capture ELISA. Allergy (1997) 0.91
Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial. Br Med J (1970) 0.91
A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso. AIDS Res Hum Retroviruses (1998) 0.90
Surveillance of human immunodeficiency virus (HIV) antibodies in medicolegal autopsies in Finland--monitoring early changes in HIV-seropositivity among risk groups and average population. J Forensic Sci (1992) 0.90
Roles and functions of a European Union Public Health Centre for Communicable Diseases and other threats to health. Euro Surveill (2002) 0.90
Are we really allergic to mosquito bites? Ann Med (1994) 0.89
Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests. J Neurol Sci (1982) 0.89
DNA sequence of the long terminal repeat of human immunodeficiency virus type 1 subtype A through G. AIDS Res Hum Retroviruses (1999) 0.89
An outbreak of the circulating recombinant form AECM240 HIV-1 in the Finnish injection drug user population. AIDS (2000) 0.88
Etiology of central nervous system infections in the Philippines and the role of serum C-reactive protein in excluding acute bacterial meningitis. Int J Infect Dis (1999) 0.87
Polyclonal antibody formation of human lymphocytes to bacterial components. Immunology (1986) 0.87
Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants. AIDS Res Hum Retroviruses (1998) 0.86
Allergens in latex surgical gloves and glove powder. Lancet (1991) 0.86
Humoral immune response in patients with IgA and IgM glomerulonephritis. Clin Exp Immunol (1986) 0.85
Evolution of the HIV epidemic in Kaliningrad, Russia. J Clin Virol (1999) 0.85
Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America. Virology (2000) 0.85
Decreased monocyte production of interleukin-1 and impaired lymphocyte proliferation in atopic dermatitis. Arch Dermatol Res (1987) 0.84
HIV-1 in Ethiopia: phylogenetic divergence from other HIV-1 strains. Virus Genes (1991) 0.84
Epidemiology of delta infection in Scandinavia. Prog Clin Biol Res (1983) 0.84
Effect of ebastine on mosquito bites. Acta Derm Venereol (1997) 0.84
Enzyme immunoassay for serum antibody to Mycoplasma hominis in women with acute pelvic inflammatory disease. Sex Transm Dis (1984) 0.84
Treatment of mosquito bites with cetirizine. Clin Exp Allergy (1993) 0.84
Foodborne outbreaks of hepatitis A in a low endemic country: an emerging problem? Epidemiol Infect (1998) 0.84
Determinants of late HIV diagnosis among different transmission groups in Finland from 1985 to 2005. HIV Med (2009) 0.83
High sensitivity for tuberculosis in a national integrated surveillance system in Finland. Euro Surveill (2005) 0.83
The role of pet cats in the seroepidemiology of toxoplasmosis. Scand J Infect Dis (1975) 0.83
Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes. Diabetologia (1988) 0.83
No seasonal distribution in subacute de Quervain's thyroiditis in Finland. J Endocrinol Invest (1989) 0.83
Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4. Childhood Diabetes in Finland Study Group. Clin Exp Immunol (1996) 0.83
Loratadine in the treatment of mosquito-bite-sensitive children. Allergy (2000) 0.82
Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non-Hodgkin lymphomas. J Pathol (1989) 0.82
Genital herpes. Virological diagnosis and antibody response. Acta Derm Venereol (1973) 0.82
Herpes simplex virus type 2 infection and cervical cancer: a prospective study of 12 years of follow-up in Finland. Cancer Causes Control (1992) 0.81
Defective HLA class II expression in monocytes of type 1 diabetic patients. The Childhood Diabetes in Finland Study Group. APMIS (1993) 0.81
Hepatitis A outbreak amongst intravenous amphetamine abusers in Finland. Scand J Infect Dis (1997) 0.81
Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 beta chain. Childhood Diabetes in Finland Study Group. Clin Exp Immunol (1994) 0.80
Epidemiology of cytomegalovirus infections during pregnancy and infancy. A prospective study. Scand J Infect Dis (1978) 0.80
Passive transfer of cutaneous mosquito-bite hypersensitivity by IgE anti-saliva antibodies. J Allergy Clin Immunol (1994) 0.80
Rubella cataract in vitro: Sensitive period of the developing human lens. J Exp Med (1975) 0.80
Mumps virus infects beta cells in human fetal islet cell cultures upregulating the expression of HLA class I molecules. Diabetologia (1992) 0.80
Mumps infections in the etiology of type 1 (insulin-dependent) diabetes. Diabetes Res (1988) 0.80
Infection by multiple viruses and lymphocyte abnormalities at the diagnosis of diabetes. Acta Paediatr Scand (1988) 0.80